| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Article |
Clinical Diabetes and Nutrition Section (N.S., J.C.B., A.D.S., P.A.T.), National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, Arizona 85016; and Department of Internal Medicine and Molecular Science (T.F., Y.M.), Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan
Address all correspondence to: Norbert Stefan, M.D., Clinical Diabetes and Nutrition Section, National Institutes of Health, 4212 North 16th Street, Room 5-41, Phoenix, Arizona 85016. E-mail: nstefan{at}mail.nih.gov.
Abstract
Adiponectin, a novel adipokine with anti-inflammatory and insulin-sensitizing properties, has been found to have independent negative associations with obesity and hyperinsulinemia/insulin resistance in adults. We measured fasting plasma adiponectin and insulin concentrations and body composition (dual-energy x-ray absorptiometry or doubly labeled water) in 30 5-yr-old (11 boys and 19 girls) and 53 10-yr-old (17 boys and 36 girls) Pima Indian children. A subgroup of 20 children (5 boys and 15 girls) had all measurements at both 5 and 10 yr of age. Cross-sectionally, plasma adiponectin concentrations were negatively correlated with percentage body fat and fasting plasma insulin concentrations at both 5 yr (r = -0.35, P = 0.06, r = -0.42, P = 0.02) and 10 yr (r = -0.46, P = 0.001, r = -0.38, P = 0.005) of age. At age 10 yr, percentage body fat (P = 0.03) but not fasting plasma insulin (P = 0.59) was independently associated with fasting plasma adiponectin concentrations. Longitudinally, plasma adiponectin concentrations decreased with increasing adiposity. In summary, these results confirm our previously reported findings in adults of an inverse relationship between plasma adiponectin concentrations and adiposity in children. Longitudinal analyses indicated that hypoadiponectinemia is a consequence of the development of obesity in childhood. We did not find evidence that adiponectin is an early mediator of obesity-induced insulin resistance, a preliminary observation that needs to be confirmed in studies using a more direct measurement of insulin action than the one used in this investigation.
This article has been cited by other articles:
![]() |
V. M. Cambuli, M. C. Musiu, M. Incani, M. Paderi, R. Serpe, V. Marras, E. Cossu, M. G. Cavallo, S. Mariotti, S. Loche, et al. Assessment of Adiponectin and Leptin as Biomarkers of Positive Metabolic Outcomes after Lifestyle Intervention in Overweight and Obese Children J. Clin. Endocrinol. Metab., August 1, 2008; 93(8): 3051 - 3057. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Barber, M. Hazell, C. Christodoulides, S. J. Golding, C. Alvey, K. Burling, A. Vidal-Puig, N. P. Groome, J. A. H. Wass, S. Franks, et al. Serum Levels of Retinol-Binding Protein 4 and Adiponectin in Women with Polycystic Ovary Syndrome: Associations with Visceral Fat But No Evidence for Fat Mass-Independent Effects on Pathogenesis in This Condition J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2859 - 2865. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sir-Petermann, M. Maliqueo, E. Codner, B. Echiburu, N. Crisosto, V. Perez, F. Perez-Bravo, and F. Cassorla Early Metabolic Derangements in Daughters of Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4637 - 4642. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Barb, C. J Williams, A. K Neuwirth, and C. S Mantzoros Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence Am. J. Clinical Nutrition, September 1, 2007; 86(3): 858S - 866S. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Siahanidou, H. Mandyla, G.-P. Papassotiriou, I. Papassotiriou, and G. Chrousos Circulating levels of adiponectin in preterm infants Arch. Dis. Child. Fetal Neonatal Ed., July 1, 2007; 92(4): F286 - F290. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Q. Shaibi, M. L. Cruz, M. J. Weigensberg, C. M. Toledo-Corral, C. J. Lane, L. A. Kelly, J. N. Davis, C. Koebnick, E. E. Ventura, C. K. Roberts, et al. Adiponectin Independently Predicts Metabolic Syndrome in Overweight Latino Youth J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1809 - 1813. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. N Evagelidou, V. I Giapros, A. S Challa, D. N Kiortsis, A. A Tsatsoulis, and S. K Andronikou Serum adiponectin levels, insulin resistance, and lipid profile in children born small for gestational age are affected by the severity of growth retardation at birth Eur. J. Endocrinol., February 1, 2007; 156(2): 271 - 277. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Willemsen, M. van Dijk, Y. B. de Rijke, A. W. van Toorenenbergen, P. G. Mulder, and A. C. Hokken-Koelega Effect of Growth Hormone Therapy on Serum Adiponectin and Resistin Levels in Short, Small-for-Gestational-Age Children and Associations with Cardiovascular Risk Parameters J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 117 - 123. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Trujillo and P. E. Scherer Adipose Tissue-Derived Factors: Impact on Health and Disease Endocr. Rev., December 1, 2006; 27(7): 762 - 778. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Araki, K. Dobashi, K. Kubo, K. Asayama, and A. Shirahata High Molecular Weight, Rather than Total, Adiponectin Levels Better Reflect Metabolic Abnormalities Associated with Childhood Obesity J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 5113 - 5116. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bronsky, M. Karpisek, E. Bronska, M. Pechova, B. Jancikova, H. Kotolova, D. Stejskal, R. Prusa, and J. Nevoral Adiponectin, Adipocyte Fatty Acid Binding Protein, and Epidermal Fatty Acid Binding Protein: Proteins Newly Identified in Human Breast Milk Clin. Chem., September 1, 2006; 52(9): 1763 - 1770. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Punthakee, E. E. Delvin, J. O'Loughlin, G. Paradis, E. Levy, R. W. Platt, and M. Lambert Adiponectin, Adiposity, and Insulin Resistance in Children and Adolescents J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2119 - 2125. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Bansal, V. Charlton-Menys, P. Pemberton, P. McElduff, J. Oldroyd, A. Vyas, A. Koudsi, P. E. Clayton, J. K. Cruickshank, and P. N. Durrington Adiponectin in Umbilical Cord Blood Is Inversely Related to Low-Density Lipoprotein Cholesterol But Not Ethnicity J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2244 - 2249. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. Ong, J. Frystyk, A. Flyvbjerg, C. J. Petry, the Avon Longitudinal Study of Parents and Childre, A. Ness, and D. B. Dunger Sex-Discordant Associations With Adiponectin Levels and Lipid Profiles in Children. Diabetes, May 1, 2006; 55(5): 1337 - 1341. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Greco, G. Latini, F. Chiarelli, P. Iannetti, and A. Verrotti Leptin, ghrelin, and adiponectin in epileptic patients treated with valproic acid Neurology, December 13, 2005; 65(11): 1808 - 1809. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Singhal, N. Jamieson, M. Fewtrell, J. Deanfield, A. Lucas, and N. Sattar Adiponectin Predicts Insulin Resistance But Not Endothelial Function in Young, Healthy Adolescents J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4615 - 4621. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Pilz, R. Horejsi, R. Moller, G. Almer, H. Scharnagl, T. Stojakovic, R. Dimitrova, G. Weihrauch, M. Borkenstein, W. Maerz, et al. Early Atherosclerosis in Obese Juveniles Is Associated with Low Serum Levels of Adiponectin J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4792 - 4796. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. F. Butte, A. G. Comuzzie, G. Cai, S. A. Cole, N. R. Mehta, and C. A. Bacino Genetic and Environmental Factors Influencing Fasting Serum Adiponectin in Hispanic Children J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4170 - 4176. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Martin, J. G. Woo, S. R. Daniels, E. Goodman, and L. M. Dolan The Relationships of Adiponectin with Insulin and Lipids Are Strengthened with Increasing Adiposity J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4255 - 4259. [Abstract] [Full Text] [PDF] |
||||
![]() |
L Hilakivi-Clarke, C Wang, M Kalil, R Riggins, and R G Pestell Nutritional modulation of the cell cycle and breast cancer Endocr. Relat. Cancer, December 1, 2004; 11(4): 603 - 622. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J Wilkin and L. D Voss Metabolic syndrome: maladaptation to a modern world J R Soc Med, November 1, 2004; 97(11): 511 - 520. [Full Text] [PDF] |
||||
![]() |
T. Reinehr, C. Roth, T. Menke, and W. Andler Adiponectin before and after Weight Loss in Obese Children J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3790 - 3794. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bottner, J. Kratzsch, G. Muller, T. M. Kapellen, S. Bluher, E. Keller, M. Bluher, and W. Kiess Gender Differences of Adiponectin Levels Develop during the Progression of Puberty and Are Related to Serum Androgen Levels J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 4053 - 4061. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. J. F. Tietge, K. H. W. Boker, M. P. Manns, and M. J. Bahr Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics Am J Physiol Endocrinol Metab, July 1, 2004; 287(1): E82 - E89. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Cruz, R. Garcia-Macedo, Y. Garcia-Valerio, M. Gutierrez, R. Medina-Navarro, G. Duran, N. Wacher, and J. Kumate Low Adiponectin Levels Predict Type 2 Diabetes in Mexican Children Diabetes Care, June 1, 2004; 27(6): 1451 - 1453. [Full Text] [PDF] |
||||
![]() |
J. B. Seo, H. M. Moon, M. J. Noh, Y. S. Lee, H. W. Jeong, E. J. Yoo, W. S. Kim, J. Park, B.-S. Youn, J. W. Kim, et al. Adipocyte Determination- and Differentiation-dependent Factor 1/Sterol Regulatory Element-binding Protein 1c Regulates Mouse Adiponectin Expression J. Biol. Chem., May 21, 2004; 279(21): 22108 - 22117. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Mantzoros, E. Petridou, N. Dessypris, C. Chavelas, M. Dalamaga, D. M. Alexe, Y. Papadiamantis, C. Markopoulos, E. Spanos, G. Chrousos, et al. Adiponectin and Breast Cancer Risk J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1102 - 1107. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cianfarani, C. Martinez, A. Maiorana, G. Scire, G. L. Spadoni, and S. Boemi Adiponectin Levels Are Reduced in Children Born Small for Gestational Age and Are Inversely Related to Postnatal Catch-Up Growth J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1346 - 1351. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-L. Tsou, Y.-D. Jiang, C.-C. Chang, J.-N. Wei, F.-C. Sung, C.-C. Lin, C.-C. Chiang, T.-Y. Tai, and L.-M. Chuang Sex-Related Differences Between Adiponectin and Insulin Resistance in Schoolchildren Diabetes Care, February 1, 2004; 27(2): 308 - 313. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Bacha, R. Saad, N. Gungor, and S. A. Arslanian Adiponectin in Youth: Relationship to visceral adiposity, insulin sensitivity, and {beta}-cell function Diabetes Care, February 1, 2004; 27(2): 547 - 552. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yamamoto, H. Hirose, I. Saito, K. Nishikai, and T. Saruta Adiponectin, an Adipocyte-Derived Protein, Predicts Future Insulin Resistance: Two-Year Follow-Up Study in Japanese Population J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 87 - 90. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Sivan, S. Mazaki-Tovi, C. Pariente, Y. Efraty, E. Schiff, R. Hemi, and H. Kanety Adiponectin in Human Cord Blood: Relation to Fetal Birth Weight and Gender J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5656 - 5660. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-C. Huang, C.-L. Chen, L.-M. Chuang, S.-R. Ho, T.-Y. Tai, and W.-S. Yang Plasma Adiponectin Levels and Blood Pressures in Nondiabetic Adolescent Females J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4130 - 4134. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Daimon, T. Oizumi, T. Saitoh, W. Kameda, A. Hirata, H. Yamaguchi, H. Ohnuma, M. Igarashi, M. Tominaga, and T. Kato Decreased Serum Levels of Adiponectin Are a Risk Factor for the Progression to Type 2 Diabetes in the Japanese Population: The Funagata study Diabetes Care, July 1, 2003; 26(7): 2015 - 2020. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Orio Jr., S. Palomba, T. Cascella, G. Milan, R. Mioni, C. Pagano, F. Zullo, A. Colao, G. Lombardi, and R. Vettor Adiponectin Levels in Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2619 - 2623. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Freemark Pharmacologic Approaches to the Prevention of Type 2 Diabetes in High Risk Pediatric Patients J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 3 - 13. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |